An interventional study of PIPA Intervention Bundle 1 and PIPA Intervention Bundle 2 in Asthma, sponsored by University of California, San Francisco. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-21.
Sponsored by University of California, San Francisco · Not applicable, Interventional, and Health services research
Background:
Asthma affects nearly 10% of American children, and is a leading cause of pediatric emergency visits and hospitalizations. Clinical pathways are operational versions of practice guidelines aimed at the hospital management of common illnesses. Single-site studies of pediatric asthma pathways have shown significant improvements in quality of care.
Primary Objective:
To evaluate the effectiveness of clinical pathways for improving quality of care for children with asthma in a diverse, national sample of emergency department (ED) and hospital settings.
Primary Endpoints:
Study Design:
This project will be implemented through an established quality improvement collaborative of hospitals across the United States, the Value in Inpatient Pediatrics Network (part of the American Academy of Pediatrics). A cluster randomized design will be employed. Group 1 hospitals will receive a multifaceted implementation strategy that includes: 1) a pathway implementation toolkit, 2) local multidisciplinary champions in the ED and inpatient settings, 3) audit and feedback, 4) educational seminars, and 5) practice facilitation (via teleconference). Group 2 will receive the same intervention with the addition of a mobile app pathway tool.
3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.
This study's enrollment of 303 is above the median of 83 across 2,752 interventional studies indexed under Asthma.
Browse Asthma studies →University of California, San Francisco is the lead sponsor of 2,132 studies on the registry; 375 are open to participants now.
Of its 262 completed or terminated interventional studies of FDA-regulated products, 196 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Participant/Local champion Eligibility Criteria:
Inclusion Criteria:
Exclusion Criteria:
Patient/child eligibility criteria:
Inclusion Criteria:
Exclusion Criteria:
Hospitals randomized to group 1 receive PIPA Intervention Bundle 1.
Behavioral: PIPA Intervention Bundle 1
Hospitals randomized to group 2 receive PIPA Intervention Bundle 2, which adds a mobile app.
Behavioral: PIPA Intervention Bundle 2
Hospitals are in the control arm (usual care) after January 2017 until active implementation begins, which includes 3-6 months of implementation preparation (identifying local multidisciplinary champions, educational sessions/webinars for local champions, one teleconference with an external practice facilitator).
The PIPA intervention bundle 1 includes: 1. Pathway Implementation Toolkit 2. Local Multidisciplinary Champions 3. Audit and Feedback 4. Educational Seminars/Webinars 5. Practice Facilitation
The PIPA intervention bundle 2 includes: 1. Pathway Implementation Toolkit 2. Local Multidisciplinary Champions 3. Audit and Feedback 4. Educational Seminars/Webinars 5. Practice Facilitation 6. Mobile App
Hospital/Inpatient: Mean length of hospital stay
Time frame: 1 year
Emergency Department: Proportion of eligible children who receive systemic steroids within 60 minutes of ED arrival
Time frame: 1 year
Hospital/Inpatient: Proportion of children with administration of bronchodilator via metered-dose inhaler early in hospitalization
Time frame: 1 year
Hospital/Inpatient: Proportion of children screened for secondhand tobacco smoke exposure
Time frame: 1 year
Hospital/Inpatient: Proportion of children who screen positive for secondhand tobacco smoke exposure whose caregivers are referred to smoking cessation resources
Time frame: 1 year
Hospital/Inpatient: Proportion of children prescribed antibiotics at hospital discharge
Time frame: 1 year
Hospital/Inpatient: Proportion of children with emergency department visits or readmissions to the hospital within 7 days
Time frame: 1 year
Hospital/Inpatient: Proportion of children transferred to a higher level of care
Time frame: 1 year
Emergency Department: Proportion of children who get an asthma exacerbation severity assessment at ED triage
Time frame: 1 year
Emergency Department: Proportion of children who have chest radiographs performed
Time frame: 1 year
Emergency Department: Proportion of children admitted to the hospital
Time frame: 1 year
Emergency Department: Proportion of children transferred to a higher level of care
Time frame: 1 year
Emergency Department: Mean length of emergency department stay
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, San Francisco